Global Cannabis Industry Round-Up

December 2025 Edition

As 2025 comes to a close, December delivered meaningful — if quieter — shifts across global cannabis markets. Rather than sweeping reforms, this month was defined by targeted regulatory action, strategic consolidation, and early signals of change heading into 2026.

Here’s your December snapshot of what’s new across Canada, the United States, and Europe — and what it means for the business and talent landscape ahead.

Canada

Strategic Consolidation Continues

December brought a notable M&A development with Canopy Growth announcing its acquisition of Québec-based MTL Cannabis. The transaction strengthens Canopy’s domestic cultivation footprint and signals continued consolidation among scaled operators seeking operational efficiency rather than pure growth.

This move reflects a broader trend: established players tightening portfolios and reinforcing core assets as margins remain under pressure across the Canadian market.

Regulatory Fine-Tuning, Not Relief

Health Canada released updates to its Forward Regulatory Plan (2025–2027), outlining longer-term intentions to align cannabis regulations more closely with international standards. While no immediate changes were announced, the plan signals potential future adjustments related to compliance, clinical trials, and reporting obligations — areas closely watched by exporters and multinational operators.

At the provincial level, Ontario updated its cannabis licensing penalty framework, adding new infractions and clarifying enforcement measures. While technical in nature, these changes underscore a continued emphasis on compliance discipline rather than regulatory easing.

White Ash Perspective:
December reinforced what Canadian operators already know: relief is unlikely in the near term. The market continues to reward organizations focused on scale discipline, compliance strength, and strategic consolidation.

United States

Federal Policy Momentum Re-Emerged

The most consequential December development came at the federal level, where renewed momentum around reclassifying cannabis from Schedule I to Schedule III sparked widespread attention across the industry and capital markets.

While implementation details remain uncertain, the possibility of rescheduling has already influenced executive planning, investor sentiment, and long-term operating assumptions — particularly around research, taxation, and regulatory treatment.

The ripple effect was immediate: cannabis equities rallied, including Canadian-listed companies with U.S. exposure, underscoring how closely global markets are tied to U.S. federal signals.

State & Municipal Regulatory Activity

December also brought several targeted regulatory actions at the state and local level:

New York - advanced stricter advertising rules for dispensaries, including limits on billboards and vehicle advertising — a sign of the state refining commercialization rules as the market matures.

In addition, a legal challenge to New York’s seed-to-sale tracking system gained traction, highlighting operator concerns over compliance costs and regulatory complexity.

At the municipal level, Glen Cove, Long Island enacted a public cannabis smoking ban, illustrating how localized policy continues to evolve independently of state legalization frameworks.

Colorado - adopted final rules designed to benefit licensees.

Ohio - capped adult-use retailers at 400 stores statewide and introduced new potency limits on cannabis concentrates, reshaping market access and product strategy for operators.

Texas - new dispensary openings moved forward despite ongoing uncertainty around THC regulation — reinforcing the state’s patchwork approach to cannabis and hemp-derived products.

White Ash Perspective:
December made one thing clear: federal signals matter, but execution still happens state by state — and sometimes city by city. Companies entering 2026 will need leadership teams capable of navigating layered regulatory environments with precision.

Europe

Infrastructure & Expansion Signals

Europe’s December activity was quieter on the policy front but meaningful in terms of investment and infrastructure:

• A new cannabis manufacturing facility announcement in Scotland signalled continued confidence in the UK’s medical cannabis and life sciences ecosystem, with long-term job creation planned.

• Across the continent, European operators continued rolling out new product lines and strategic acquisitions, positioning themselves ahead of broader market liberalization expected in the coming years.

While headline reform stalled in December, capital deployment and operational build-out suggest confidence in Europe’s long-term trajectory.

Talent Implications

European companies are increasingly recruiting leaders with:

• EU-GMP manufacturing expertise

• Cross-border regulatory experience

• International expansion backgrounds

North American executives with prior global scaling experience continue to be drawn into senior European roles.

White Ash Perspective:
Europe’s cannabis market is being built deliberately. December’s developments point to execution behind the scenes — infrastructure, talent, and positioning — rather than public policy announcements.

The Talent Take

December’s developments reinforced a global shift already underway:

• Less emphasis on rapid expansion

• Greater demand for regulatory fluency and operational leadership

• Rising importance of executives who can manage complexity across jurisdictions

Across Canada, the U.S., and Europe, cannabis companies are preparing for 2026 by strengthening leadership benches rather than chasing short-term growth.

White Ash Group continues to support this evolution by connecting experienced, globally minded leaders with cannabis organizations navigating the next phase of maturity.

Closing Thought

December didn’t bring sweeping reform — but it did bring clarity.

As the industry turns the page to 2026, the winners will be those who used this quieter month to position themselves strategically: tightening operations, strengthening leadership, and preparing for the regulatory and market shifts ahead.

Subscribe to the White Ash Group Global Cannabis Industry Round-Up for monthly insights from our international team.

Follow us on LinkedIn for leadership perspectives, talent trends, and updates across Canada, the United States, and Europe.